Healthpeak Properties (NYSE:DOC) Posts Earnings Results, Beats Expectations By $0.01 EPS

Key Points

• Healthpeak Properties reported a quarterly earnings per share (EPS) of $0.46, exceeding analysts' expectations of $0.45 by $0.01.
• The company announced a monthly dividend of $0.1017 per share, with a dividend yield of 6.6%, which will be paid on December 30th.
• Healthpeak Properties' stock currently has an average rating of "Moderate Buy" with a consensus price target of $21.33 per share.

Healthpeak Properties (NYSE:DOC - Get Free Report) released its quarterly earnings results on Thursday. The real estate investment trust reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.01, Zacks reports. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. Healthpeak Properties updated its FY 2025 guidance to 1.810-1.870 EPS.

Healthpeak Properties Price Performance

Healthpeak Properties stock traded down $0.08 during mid-day trading on Thursday, hitting $18.54. The company's stock had a trading volume of 7,319,137 shares, compared to its average volume of 6,499,538. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The stock has a market capitalization of $12.89 billion, a P/E ratio of 77.27, a P/E/G ratio of 3.17 and a beta of 1.09. Healthpeak Properties has a twelve month low of $16.63 and a twelve month high of $23.26. The stock's fifty day moving average price is $18.26 and its two-hundred day moving average price is $17.90.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a $0.1017 dividend. The ex-dividend date is Friday, December 19th. This represents a c) annualized dividend and a yield of 6.6%. Healthpeak Properties's payout ratio is 508.33%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Wells Fargo & Company cut their price target on Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 27th. Scotiabank cut Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and dropped their target price for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Morgan Stanley dropped their target price on Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a report on Friday, August 22nd. Finally, Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $21.33.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 2,930 shares of the firm's stock in a transaction on Thursday, July 31st. The shares were purchased at an average price of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the transaction, the chief executive officer owned 210,416 shares in the company, valued at $3,589,696.96. This represents a 1.41% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have purchased a total of 8,783 shares of company stock valued at $150,129 in the last quarter. Insiders own 0.23% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Corient Private Wealth LLC grew its holdings in shares of Healthpeak Properties by 1.0% during the 2nd quarter. Corient Private Wealth LLC now owns 104,109 shares of the real estate investment trust's stock valued at $1,823,000 after acquiring an additional 1,010 shares in the last quarter. Integrated Wealth Concepts LLC grew its holdings in shares of Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust's stock valued at $366,000 after acquiring an additional 1,231 shares in the last quarter. Binnacle Investments Inc grew its holdings in shares of Healthpeak Properties by 19.2% during the 2nd quarter. Binnacle Investments Inc now owns 8,247 shares of the real estate investment trust's stock valued at $144,000 after acquiring an additional 1,327 shares in the last quarter. Brown Advisory Inc. boosted its holdings in Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust's stock worth $819,000 after purchasing an additional 1,415 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its holdings in Healthpeak Properties by 18.5% in the second quarter. Geneos Wealth Management Inc. now owns 10,150 shares of the real estate investment trust's stock worth $178,000 after purchasing an additional 1,584 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.